We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
-18.82%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.03B
AUM Growth
-$200M
Cap. Flow
+$16M
Cap. Flow %
1.55%
Top 10 Hldgs %
58.26%
Holding
811
New
317
Increased
98
Reduced
90
Closed
269

Top Buys

Rank Stock Value
1
VAL icon
Valaris
VAL
+$24.3M
2
MRNA icon
Moderna
MRNA
+$9.63M
3
SLV icon
iShares Silver Trust
SLV
+$9.23M
4
TMUS icon
T-Mobile US
TMUS
+$9.02M
5
NE icon
Noble Corp
NE
+$6.74M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$107M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$29M
3
APTV icon
Aptiv
APTV
+$22.6M
4
MSFT icon
Microsoft
MSFT
+$20.8M
5
AMZN icon
Amazon
AMZN
+$12.7M

Sector Composition

Rank Sector Weight
1 Healthcare 23.31%
2 Consumer Discretionary 12.31%
3 Materials 12.15%
4 Industrials 5.19%
5 Financials 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORC
526
Orchid Island Capital
ORC
$1.31B
$71K 0.01%
+4,974
New +$73.8K
TCS
527
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$65K 0.01%
+695
New +$78.8K
FLL icon
528
Full House Resorts
FLL
$89M
$64K 0.01%
10,569
AUD
529
DELISTED
Audacy, Inc.
AUD
$64K 0.01%
67,644
EXTN
530
DELISTED
Exterran Corporation
EXTN
$61K 0.01%
+14,274
New +$86.4K
MGNX icon
531
MacroGenics
MGNX
$257M
$52K 0.01%
+17,609
New +$92.6K
CO
532
DELISTED
Global Cord Blood Corporation
CO
$49K ﹤0.01%
+16,648
New +$51.6K
QUOT
533
DELISTED
Quotient Technology Inc
QUOT
$48K ﹤0.01%
+16,215
New +$76.9K
NPKI
534
NPK International
NPKI
$1.14B
$45K ﹤0.01%
14,446
EGIO
535
DELISTED
Edgio, Inc. Common Stock
EGIO
$43K ﹤0.01%
460
-1,667
-78% -$240K
YELL
536
DELISTED
Yellow Corporation Common Stock
YELL
$42K ﹤0.01%
+14,232
New +$57.7K
AFMD
537
DELISTED
Affimed
AFMD
$41K ﹤0.01%
+1,471
New +$50.4K
ADAP
538
DELISTED
Adaptimmune Therapeutics
ADAP
$39K ﹤0.01%
+23,034
New +$39.6K
XLF icon
539
State Street Financial Select Sector SPDR ETF
XLF
$58.8B
$39K ﹤0.01%
1,250
CANG
540
Cango Inc
CANG
$68.5M
$31K ﹤0.01%
+1,357
New +$39.2K
EXPR
541
DELISTED
Express, Inc.
EXPR
$30K ﹤0.01%
+754
New +$45.3K
CMCM
542
Cheetah Mobile
CMCM
$96.5M
$28K ﹤0.01%
8,011
AAON icon
543
Aaon
AAON
$7.77B
-22,001
Closed -$817K
AAPL icon
544
Apple
AAPL
$4.57T
-43,331
Closed -$6.56M
ADP icon
545
Automatic Data Processing
ADP
$108B
-2,460
Closed -$560K
ADPT icon
546
Adaptive Biotechnologies
ADPT
$3.97B
-30,690
Closed -$426K
ADVM
547
DELISTED
Adverum Biotechnologies
ADVM
-32,554
Closed -$426K
AES icon
548
AES
AES
$10.5B
-7,900
Closed -$203K
AFG icon
549
American Financial Group
AFG
$12.1B
-1,466
Closed -$213K
AFL icon
550
Aflac
AFL
$62.6B
-7,911
Closed -$509K

Similar funds

Caxton Associates (New York)'s Q2 2022 Portfolio in Review

As of Q2 2022, Caxton Associates (New York) held 811 positions worth $1.03B, down 16% from $1.23B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Caxton Associates (New York)'s Q2 2022 filing shows 317 new, 98 increased, 90 reduced and 269 closed positions. Its largest new stake was Valaris: 451,426 shares worth $19.1M. The largest sale was Tesla, an estimated $107M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Materials.

  • Caxton Associates (New York)'s largest Q2 2022 buy was Valaris: 451,426 shares worth $19.1M.
  • Caxton Associates (New York) added most to Moderna in Q2 2022, an estimated $9.63M increase.
  • Caxton Associates (New York)'s biggest Q2 2022 reduction was Aptiv, cutting an estimated $22.6M.
  • Caxton Associates (New York) fully exited Tesla in Q2 2022, selling an estimated $107M.
  • Caxton Associates (New York)'s ten largest holdings make up 58% of its $1.03B portfolio in Q2 2022.
  • Caxton Associates (New York) opened 317 new positions and closed 269 in Q2 2022.
  • Caxton Associates (New York)'s portfolio value fell 16% quarter-over-quarter to $1.03B.

Based on Caxton Associates (New York)'s 13F filing for Q2 2022, filed 15 Aug 2022.